Literature DB >> 35026504

Astragaloside IV pre-treatment attenuates PM2.5-induced lung injury in rats: Impact on autophagy, apoptosis and inflammation.

Zhenxing Wang1, Yongcan Wu1, Caixia Pei1, Mingjie Wang1, Xiaomin Wang1, Shihua Shi1, Demei Huang1, Yilan Wang1, Shuiqin Li1, Wei Xiao1, Yacong He2, Fei Wang3.   

Abstract

BACKGROUND: Fine particulate matter (PM2.5) with an aerodynamic diameter of less than 2.5 μm, exerts serious lung toxicity. At present, effective prevention measures and treatment modalities for pulmonary toxicity caused by PM2.5 are lacking. Astragaloside IV (AS-IV) is a natural product that has received increasing attention from researchers for its unique biological functions.
PURPOSE: To investigate the protective effects of AS-IV on PM2.5-induced pulmonary toxicity and identify its potential mechanisms.
METHODS: The rat model of PM2.5-induced lung toxicity was created by intratracheal instillation of PM2.5 dust suspension. The investigation was performed with AS-IV or in combination with autophagic flux inhibitor (Chloroquine) or AMP-sensitive protein kinase (AMPK)-specific inhibitor (Compound C). Apoptosis was detected by terminal deoxy-nucleotidyl transferase dUTP nick end labeling (TUNEL) and western blotting. Autophagy was detected by immunofluorescence staining, autophagic flux measurement, western blotting, and transmission electron microscopy. The AMPK/mTOR pathway was analyzed by western blotting. Inflammation was analyzed by western blotting and suspension array.
RESULTS: AS-IV prevented histopathological injury, inflammation, autophagy dysfunction, apoptosis, and changes in AMPK levels induced by PM2.5. AS-IV increased autophagic flux and inhibited apoptosis and inflammation by activating the AMPK/ mammalian target of rapamycin (mTOR) pathway. However, AS-IV had no protective effect on PM2.5-induced lung injury following treatment with Compound C or Chloroquine.
CONCLUSION: AS-IV prevented PM2.5-induced lung toxicity by restoring the balance among autophagy, apoptosis, and inflammation in rats by activating the AMPK/mTOR signaling pathway.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Astragaloside iv; Autophagic flux; Lung toxicity; Pm2.5

Mesh:

Substances:

Year:  2021        PMID: 35026504     DOI: 10.1016/j.phymed.2021.153912

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  1 in total

Review 1.  Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.

Authors:  Ying Yang; Meng Hong; Wen-Wen Lian; Zhi Chen
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.